Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acta Naturae ; 15(1): 26-30, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37153504

RESUMEN

Catalepsy is a behavioral condition that is associated with severe psychopathologies, including schizophrenia, depression, and Parkinson's disease. In some mouse strains, catalepsy can be induced by pinching the skin at the scruff of the neck. The main locus of hereditary catalepsy in mice has recently been linked to the 105-115 Mb fragment of mouse chromosome 13 by QTL analysis. We performed whole-genome sequencing of catalepsy-resistant and catalepsy-prone mouse strains in order to pinpoint the putative candidate genes related to hereditary catalepsy in mice. We remapped the previously described main locus for hereditary catalepsy in mice to the chromosome region 103.92-106.16 Mb. A homologous human region on chromosome 5 includes genetic and epigenetic variants associated with schizophrenia. Furthermore, we identified a missense variant in catalepsy-prone strains within the Nln gene. Nln encodes neurolysin, which degrades neurotensin, a peptide reported to induce catalepsy in mice. Our data suggest that Nln is the most probable candidate for the role of major gene of hereditary, pinch-induced catalepsy in mice and point to a shared molecular pathway between catalepsy in mice and human neuropsychiatric disorders.

2.
Biochemistry (Mosc) ; 82(8): 962-971, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28941465

RESUMEN

LINE1 retrotransposons are members of a class of mobile genetic elements capable of retrotransposition in the genome via a process of reverse transcription. LINE1 repeats, integrating into different chromosomal loci, affect the activity of genes and cause different genomic mutations. Somatic variability of the human genome is linked to the activity of some subfamilies of LINE1, in particular, a high level of LINE1 retrotranspositions has been observed in brain tissues. However, the contribution of LINE1 to genomic variability during normal aging and in age-related neurodegenerative diseases is poorly understood. We conducted quantitative real-time PCR analysis of active subfamilies of LINE1 repeats (aL1) using genomic DNA extracted from brain specimens of Alzheimer's disease (AD) patients and individuals without neuropsychiatric pathologies, as well as DNA extracted from blood specimens of individuals of different ages (healthy and AD subjects). Inter-individual quantitative variations of active families of aL1 repeats in the genome were observed. No significant age-dependent differences were identified. Likewise, no difference of aL1 copy number in brain and blood were indicated between AD patients and the aged-matched control group without dementia. These data imply that aging and the AD-associated neurodegenerative process are not the major factors contributing to the retrotransposition processes of active LINE1 repeats.


Asunto(s)
Envejecimiento , Enfermedad de Alzheimer/patología , Elementos de Nucleótido Esparcido Largo/genética , Regiones no Traducidas 5' , Anciano , Enfermedad de Alzheimer/metabolismo , Estudios de Casos y Controles , Femenino , Lóbulo Frontal/metabolismo , Genoma Humano , Humanos , Masculino , Persona de Mediana Edad , ARN Ribosómico 5S/genética , ARN Ribosómico 5S/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa
3.
Mol Phylogenet Evol ; 107: 232-238, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27845203

RESUMEN

Turritopsis dohrnii (Cnidaria, Hydrozoa, Hydroidolina, Anthoathecata) is the only known metazoan that is capable of reversing its life cycle via morph rejuvenation from the adult medusa stage to the juvenile polyp stage. Here, we present a complete mitochondrial (mt) genome sequence of T. dohrnii, which harbors genes for 13 proteins, two transfer RNAs, and two ribosomal RNAs. The T. dohrnii mt genome is characterized by typical features of species in the Hydroidolina subclass, such as a high A+T content (71.5%), reversed transcriptional orientation for the large rRNA subunit gene, and paucity of CGN codons. An incomplete complementary duplicate of the cox1 gene was found at the 5' end of the T. dohrnii mt chromosome, as were variable repeat regions flanking the chromosome. We identified species-specific variations (nad5, nad6, cob, and cox1 genes) and putative selective constraints (atp8, nad1, nad2, and nad5 genes) in the mt genes of T. dohrnii, and predicted alterations in tertiary structures of respiratory chain proteins (NADH4, NADH5, and COX1 proteins) of T. dohrnii. Based on comparative analyses of available hydrozoan mt genomes, we also determined the taxonomic relationships of T. dohrnii, recovering Filifera IV as a paraphyletic taxon, and assessed intraspecific diversity of various Hydrozoa species.


Asunto(s)
Evolución Biológica , Genoma Mitocondrial , Estadios del Ciclo de Vida/genética , Escifozoos/crecimiento & desarrollo , Escifozoos/genética , Animales , Secuencia de Bases , ADN Mitocondrial/genética , Genes Mitocondriales , Variación Genética , Nucleótidos/genética , Sistemas de Lectura Abierta/genética , Filogenia , ARN Ribosómico/genética
4.
Sci Rep ; 6: 26440, 2016 05 24.
Artículo en Inglés | MEDLINE | ID: mdl-27216912

RESUMEN

Tumors of the jaws may represent different human disorders and frequently associate with pathologic bone fractures. In this report, we analyzed two affected siblings from a family of Russian origin, with a history of dental tumors of the jaws, in correspondence to original clinical diagnosis of cementoma consistent with gigantiform cementoma (GC, OMIM: 137575). Whole exome sequencing revealed the heterozygous missense mutation c.1067G > A (p.Cys356Tyr) in ANO5 gene in these patients. To date, autosomal-dominant mutations have been described in the ANO5 gene for gnathodiaphyseal dysplasia (GDD, OMIM: 166260), and multiple recessive mutations have been described in the gene for muscle dystrophies (OMIM: 613319, 611307); the same amino acid (Cys) at the position 356 is mutated in GDD. These genetic data and similar clinical phenotypes demonstrate that the GC and GDD likely represent the same type of bone pathology. Our data illustrate the significance of mutations in single amino-acid position for particular bone tissue pathology. Modifying role of genetic variations in another gene on the severity of the monogenic trait pathology is also suggested. Finally, we propose the model explaining the tissue-specific manifestation of clinically distant bone and muscle diseases linked to mutations in one gene.


Asunto(s)
Anoctaminas/genética , Secuenciación del Exoma/métodos , Neoplasias Maxilomandibulares/genética , Distrofias Musculares/genética , Mutación Missense , Análisis de Secuencia de ADN/métodos , Anoctaminas/química , Cementoma/genética , Niño , Femenino , Estudios de Asociación Genética , Humanos , Masculino , Modelos Moleculares , Osteogénesis Imperfecta/genética , Linaje , Federación de Rusia
5.
Mol Biol (Mosk) ; 44(4): 620-6, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-20873220

RESUMEN

Three genes mutations in which cause familial forms of Alzheimer's disease are known to date:PSEN1, PSEN2 and APP; and APOE gene polymorphism is a strong risk factor for Alzheimer's disease. We have evaluated allele and genotype frequency distribution of rs11136000 polymorphism in clusterin (CLU) gene (or apolipoprotein J, APOJ) in populations of three Russian regions and i nAlzheimhner's diseasepatients. Genome-wideassociation studies in samples from several European populations have recently revealed highly significant association o fCLU gene with AD (p = 8.5 x 10(-10)). We found no differences in allele and genotype frequencies of rs11136000 between populations from Moscow, Ural and Siberia regions. The allele frequencies are close to those in European populations. The genetic association analysis in cohort of Alzheimer's disease patients and normal individuals (>500 individuals ineach group) revealed no significant association of the rs11136000 polymorphism in CLU with Alzheimer's disease in Russian populations. Although our resultsdo not confirm the role of CLU gene as a majorgenetic factor forcommon form of Alzheimer's disease, the data do not rule out the possibility of modest effect of CLU and interaction between CLU and APOE genotypes in etiology of Alzheimer's disease.


Asunto(s)
Alelos , Enfermedad de Alzheimer/genética , Clusterina/genética , Frecuencia de los Genes/genética , Polimorfismo Genético/genética , Adulto , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/epidemiología , Estudios de Cohortes , Femenino , Estudio de Asociación del Genoma Completo , Humanos , Masculino , Persona de Mediana Edad , Federación de Rusia/epidemiología
6.
Acta Naturae ; 1(3): 58-69, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22649615

RESUMEN

Studies of ancient DNA specimens started 25 years ago. At that time short mitochondrial DNA (mtDNA) fragments were the main targets in ancient DNA studies. The last three years were especially productive in the development of new methods of DNA purification and analysis. Complete mtDNA molecules and relatively large fragments of nuclear DNA are the targets of ancient DNA studies today. Ancient DNA studies allowed us to study organisms that went extinct more than ten thousand years ago, to reconstruct their phenotypic traits and evolution. Ancient DNA analyses can help understand the development of ancient human populations and how they migrated. A new evolutionary hypothesis and reconstruction of the biota history have been re-created from recent ancient DNA data. Some peculiarities and problems specific to the study of ancient DNA were revealed, such as very limited amounts of DNA available for study, the short length of the DNA fragments, breaks and chemical modifications in DNA molecules that result in "postmortem" mutations or complete blockage of DNA replication in vitro. The same specific features of DNA analysis were revealed for specimens from complicated forensic cases that result in the lack of experimental data or interpretation problems.. Here, we list the specific features of ancient DNA methodology and describe some achievements in fundamental and applied research of ancient DNA, including our own work in the field.

7.
Mol Biol (Mosk) ; 42(5): 751-64, 2008.
Artículo en Ruso | MEDLINE | ID: mdl-18988525

RESUMEN

MicroRNAs (miRNAs) are a class of RNA which controls gene expression at the posttranscription level. Binding with the target RNA, a miRNA can supress translation and/or induce degradation of mRNA. The studies of miRNAs have already shown that miRNA were essential to switch the programs of gene expression during embryo development as well as to control cell functioning of the adult organism. Alteration of the miRNA expression profile may appear not less important in development of pathology than better known structural variations of the proteins. The role of miRNA has been confirmed for a range of common diseases connected to impaired balance of cell proliferation, differentiation and programmed death. This review discusses specific features of miRNA-mediated regulation of gene expression and its role in normal and pathological development of muscle, immune, and nervous systems. The evidence of miRNA involvent in neurodegenerative disorders and mental disorders is demonstrated.


Asunto(s)
MicroARNs/fisiología , Enfermedades Cardiovasculares/metabolismo , Enfermedades Cardiovasculares/patología , Muerte Celular/fisiología , Diferenciación Celular/fisiología , Proliferación Celular , Humanos , Sistema Inmunológico/fisiología , Trastornos Mentales/metabolismo , Trastornos Mentales/patología , MicroARNs/genética , Músculo Esquelético/fisiología , Miocardio/metabolismo , Miocardio/patología , Neoplasias/metabolismo , Neoplasias/patología , Sistema Nervioso/metabolismo , Sistema Nervioso/patología , Enfermedades del Sistema Nervioso/metabolismo , Enfermedades del Sistema Nervioso/patología , Especificidad de Órganos
8.
Mol Biol (Mosk) ; 41(2): 331-45, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17514900

RESUMEN

Studies of molecular mechanisms for Alzheimer's Disease have led to the two major achievements. First, genes with mutations causing Alzheimer's Disease (presenilin genes PSI, PS2 and APP) or bearing a risk factor polymorphism (ApoE) for Alzheimer's Disease were described. Second, the new type of proteases and mechanisms of regulation of cellular differentiation and development by processes of intramembrane proteolysis were identified. These mechanisms, apparently, are universal for various cell types and organisms. Presenilin is a catalytic component of tetra-protein complex (epsilon-/gamma-secretase) cleaving type I transmembrane proteins. Other recently discovered aspartate proteases, IMPAS/SPP, cleave type II transmembrane proteins. Processing of transmembrane proteins by cellular intramembrane proteases results in production of signal peptides, transcriptional factors and short hydrophobic proteins (fragments of transmembrane domains), which may have a physiological function or play a key role in patogenic events associated with ageing (e.g., beta-amyloid formation in Alzheimer's Disease). To date approximately 160 mutations in PSI gene, more than 10 mutations in PS2 gene and 21 mutations in APP gene were described. Early preclinical diagnostics of some early forms of Alzheimer's Disease became possible. Since patogeneses of early and late onset forms of Alzheimer's Disease are similar, identification of molecular or epigenetic factors affecting primary molecular mechanisms (intramembrane or membrane associated proteolysis) underlying the disease may ultimately contribute to development of rational therapy for Alzheimer's Disease.


Asunto(s)
Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Membrana Celular/enzimología , Presenilinas/metabolismo , Receptores de Superficie Celular/metabolismo , Enfermedad de Alzheimer/terapia , Secuencia de Aminoácidos , Secretasas de la Proteína Precursora del Amiloide/análisis , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Precursor de Proteína beta-Amiloide/genética , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Humanos , Datos de Secuencia Molecular , Mutación , Péptido Hidrolasas/análisis , Péptido Hidrolasas/metabolismo , Presenilinas/genética , Nexinas de Proteasas , Receptores de Superficie Celular/genética
10.
Biochemistry (Mosc) ; 68(6): 611-7, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12943504

RESUMEN

Missense mutations in human presenilin 1 gene (hPS1) cause an autosomal dominant, early onset form of Alzheimer's disease (AD). To study effects of mutant presenilin on processes of cell growth, differentiation, and susceptibility to apoptotic signals, we produced a series of rat pheochromocytoma PC12 poly- and monoclonal cell lines stably expressing wild type hPS1 and hPS1 with mutations in amino (N-) and carboxyl (C-) terminal regions of the PS1 protein. Employing a heterologous rat PC12 cell system, we demonstrated that: 1) AD mutations inhibit, in part, processing of hPS1 holoprotein; 2) negative selection against highly expressed hPS1 may occur in polyclonal cell cultures; 3) expression of N-terminus mutant (M146V) hPS1 increases susceptibility to apoptosis in differentiated neuronal PC12 cells under deprivation conditions; 4) monoclones with hPS1 C-terminal AD mutation (C410Y) have lower proliferation rates than monoclones expressing wild type hPS1 under deprivation conditions and during NGF-induced neuronal differentiation. The data demonstrate deleterious effect of PS1 AD mutations. The effect depends on the level of expression of the hPS1 isoforms, the number of passages, and trophic and differentiation conditions used for growing PC12 cells.


Asunto(s)
Proteínas de la Membrana/genética , Enfermedad de Alzheimer/genética , Sustitución de Aminoácidos , Animales , Apoptosis/genética , Western Blotting , Recuento de Células , Técnicas de Cultivo de Célula/métodos , División Celular/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Clonales , Humanos , Proteínas de la Membrana/farmacología , Células PC12 , Presenilina-1 , Isoformas de Proteínas/genética , Isoformas de Proteínas/farmacología , Ratas , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología , Transfección
12.
Biochemistry (Mosc) ; 67(7): 826-35, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12139484

RESUMEN

A significant proportion of early onset Alzheimer's disease (AD) is caused by mutations in human genes for amyloid precursor protein (APP), presenilins 1 and 2 (PSEN1,2). AD associated mutations in PSEN1,2 genes alter the gamma-secretase cleavage activity of APP resulting in increased production of amyloidogenic Abeta42. PSEN dependent intramembrane proteolysis was described as an important step required for cleavage of Notch receptors, Notch-dependent signal transduction, and processing of other proteins. It is still unclear whether presenilins are unusual intramembrane proteases or they are necessary cofactors of gamma-secretase cleavage of APP and Notch. Identification of other proteins similar to presenilins may resolve this dilemma. We describe here the identification of novel families of genes encoding polytopic transmembrane proteins of Eukaryotes (IMPASes) and Arachaea(membrases). These proteins have a predicted structure similar to presenilins. The amino acid similarity is significant in domains carrying invariant amino acid residues, which are critical in specific presenilin-regulated endoproteolysis. Many members of the IMPAS family have protease associated domains (PA) typical of proteases. We identified and cloned five human IMPAS genes. Expression analysis of the hIMP1 gene (located on chromosome 20) was performed in human cell tissues and transfected cell cultures. The data demonstrate that a conservative class of putative protease-related polytopic proteins related to presenilins exists in multicellular eukaryotes and microorganisms.


Asunto(s)
Endopeptidasas/química , Endopeptidasas/clasificación , Endopeptidasas/metabolismo , Proteínas de Saccharomyces cerevisiae , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Línea Celular , Clonación Molecular , Endopeptidasas/genética , Perfilación de la Expresión Génica , Humanos , Proteínas de la Membrana/química , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Datos de Secuencia Molecular , Presenilina-1 , Presenilina-2 , Estructura Terciaria de Proteína , ARN Mensajero/genética , ARN Mensajero/metabolismo , Alineación de Secuencia , Homología de Secuencia
13.
Genetika ; 32(12): 1661-8, 1996 Dec.
Artículo en Ruso | MEDLINE | ID: mdl-9102356

RESUMEN

The bacterial gene for beta-galactosidase under the control of LTR from either human cytomegalovirus (CMV-lacZ) or the Rous sarcoma virus (RSV-lacZ) was injected into fertilized eggs of Misgurnus fossilis L. loaches and F1 hybrid mice (CBA x C57Bl). Expression of the CMV-lacZ was observed in almost 100% of the loach embryos and larvae for two months following the first day of embryonic development. In some cases, expression points were located only on either the right or the left side of a fish. The spectrum of tissues expressing CMV-lacZ was decreased during embryonic development: CMV-lacZ was expressed only in fin and body muscles of 6- to 8-week-old loaches. In mice, the RSV-lacZ gene was expressed in ectoderm- and mesoderm-derived tissues of a 13-day-old embryo, and the CMV-lacZ gene was expressed in tissues derived from various blastophylli of a 14-day-old embryo. Distribution of transgene expression is discussed with regard to authors' and published data.


Asunto(s)
Virus del Sarcoma Aviar/genética , Citomegalovirus/genética , Regulación del Desarrollo de la Expresión Génica/fisiología , Genes Virales , Operón Lac , Animales , Animales Modificados Genéticamente , Cipriniformes/genética , Desarrollo Embrionario y Fetal/genética , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA
14.
Vrach Delo ; (6): 87-90, 1989 Jun.
Artículo en Ruso | MEDLINE | ID: mdl-2781775

RESUMEN

A study is presented of 17 patients--9 with myasthenia, 8 with the Guillain--Barré syndrome. The complex treatment program of intensive therapy and reanimation included in all patients the operation of extracorporal heterospleen. Forty-one perfusions were carried out. The operation of splenic sorption allowed to reduce treatment time under conditions of intensive care and reanimation 1.5 times, lethality--by 33%. Employment of biological sorption in patients with such immunoneurological diseases as myasthenia and the Guillain--Barré syndrome removes the humoral autoallergic factor and, thus, favours restoration of nervous system function.


Asunto(s)
Hemoperfusión/métodos , Miastenia Gravis/terapia , Polirradiculoneuropatía/terapia , Adolescente , Adulto , Animales , Terapia Combinada , Urgencias Médicas , Femenino , Humanos , Masculino , Resucitación , Bazo , Porcinos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...